Woerner BM - Search Results

1

Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo.

Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB. Yang L, et al. Among authors: woerner bm. Cancer Res. 2007 Jan 15;67(2):651-8. doi: 10.1158/0008-5472.CAN-06-2762. Cancer Res. 2007. PMID: 17234775

2

Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies.

Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB. Woerner BM, et al. Cancer Res. 2005 Dec 15;65(24):11392-9. doi: 10.1158/0008-5472.CAN-05-0847. Cancer Res. 2005. PMID: 16357147

3

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

Warrington NM, Woerner BM, Daginakatte GC, Dasgupta B, Perry A, Gutmann DH, Rubin JB. Warrington NM, et al. Among authors: woerner bm. Cancer Res. 2007 Sep 15;67(18):8588-95. doi: 10.1158/0008-5472.CAN-06-2220. Cancer Res. 2007. PMID: 17875698

4

Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.

Goldhoff P, Warrington NM, Limbrick DD Jr, Hope A, Woerner BM, Jackson E, Perry A, Piwnica-Worms D, Rubin JB. Goldhoff P, et al. Among authors: woerner bm. Clin Cancer Res. 2008 Dec 1;14(23):7717-25. doi: 10.1158/1078-0432.CCR-08-0827. Clin Cancer Res. 2008. PMID: 19047098 Free PMC article.

5

CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma.

Sengupta R, Dubuc A, Ward S, Yang L, Northcott P, Woerner BM, Kroll K, Luo J, Taylor MD, Wechsler-Reya RJ, Rubin JB. Sengupta R, et al. Among authors: woerner bm. Cancer Res. 2012 Jan 1;72(1):122-32. doi: 10.1158/0008-5472.CAN-11-1701. Epub 2011 Nov 3. Cancer Res. 2012. PMID: 22052462 Free PMC article.

6

Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.

Woerner BM, Luo J, Brown KR, Jackson E, Dahiya SM, Mischel P, Benovic JL, Piwnica-Worms D, Rubin JB. Woerner BM, et al. Mol Cancer Res. 2012 Jan;10(1):156-66. doi: 10.1158/1541-7786.MCR-11-0411. Epub 2011 Nov 15. Mol Cancer Res. 2012. PMID: 22086906 Free PMC article.

7

CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.

Rao S, Sengupta R, Choe EJ, Woerner BM, Jackson E, Sun T, Leonard J, Piwnica-Worms D, Rubin JB. Rao S, et al. Among authors: woerner bm. PLoS One. 2012;7(3):e33005. doi: 10.1371/journal.pone.0033005. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22427929 Free PMC article.

8

Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.

McCandless EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH, Klein RS. McCandless EE, et al. Among authors: woerner bm. Am J Pathol. 2008 Mar;172(3):799-808. doi: 10.2353/ajpath.2008.070918. Epub 2008 Feb 14. Am J Pathol. 2008. PMID: 18276777 Free PMC article.

9

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. Masferrer JL, et al. Among authors: woerner bm. Cancer Res. 2000 Mar 1;60(5):1306-11. Cancer Res. 2000. PMID: 10728691

10

CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis.

McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS. McCandless EE, et al. Among authors: woerner bm. J Immunol. 2006 Dec 1;177(11):8053-64. doi: 10.4049/jimmunol.177.11.8053. J Immunol. 2006. PMID: 17114479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters